Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (461-470 of 490) with videos related to

Pageof 49
Sort By:
Blood|May 15, 1997
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trialH J Deeg, D Lin, W Leisenring, et al.
Blood|July 10, 1998
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phaseA J Morton, T Gooley, J A Hansen, et al.
Blood|April 1, 1983
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?R Storb, R L Prentice, M Banaji, et al.
Blood|June 1, 1997
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell doseJ Sierra, B Storer, J A Hansen, et al.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Blood|March 1, 1981
Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twinsA Fefer, M A Cheever, E D Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantationK M Sullivan, E Kansu, B Storer, et al.
Leukemia|August 13, 2014
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer CenterR B Walter, M Othus, A K Burnett, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescueS Y Liu, J F Eary, S H Petersdorf, et al.
Pageof 49

Showing results (461-470 of 490) with videos related to

Sort By:
Pageof 49
Blood|May 15, 1997
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trialH J Deeg, D Lin, W Leisenring, et al.
Blood|July 10, 1998
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phaseA J Morton, T Gooley, J A Hansen, et al.
Blood|April 1, 1983
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?R Storb, R L Prentice, M Banaji, et al.
Blood|June 1, 1997
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell doseJ Sierra, B Storer, J A Hansen, et al.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Blood|March 1, 1981
Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twinsA Fefer, M A Cheever, E D Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantationK M Sullivan, E Kansu, B Storer, et al.
Leukemia|August 13, 2014
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer CenterR B Walter, M Othus, A K Burnett, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescueS Y Liu, J F Eary, S H Petersdorf, et al.
Pageof 49